| Literature DB >> 26818466 |
E Barca1,2, O Musumeci2,3, F Montagnese2, S Marino3,4, F Granata4, D Nunnari3, L Peverelli1, S DiMauro1, C M Quinzii1, A Toscano2,3.
Abstract
Inherited ataxias are a group of heterogeneous disorders in children or adults but their genetic definition remains still undetermined in almost half of the patients. However, CoQ10 deficiency is a rare cause of cerebellar ataxia and ADCK3 is the most frequent gene associated with this defect. We herein report a 48 year old man, who presented with dysarthria and walking difficulties. Brain magnetic resonance imaging showed a marked cerebellar atrophy. Serum lactate was elevated. Tissues obtained by muscle and skin biopsies were studied for biochemical and genetic characterization. Skeletal muscle biochemistry revealed decreased activities of complexes I+III and II+III and a severe reduction of CoQ10 , while skin fibroblasts showed normal CoQ10 levels. A mild loss of maximal respiration capacity was also found by high-resolution respirometry. Molecular studies identified a novel homozygous deletion (c.504del_CT) in ADCK3, causing a premature stop codon. Western blot analysis revealed marked reduction of ADCK3 protein levels. Treatment with CoQ10 was started and, after 1 year follow-up, patient neurological condition slightly improved. This report suggests the importance of investigating mitochondrial function and, in particular, muscle CoQ10 levels, in patients with adult-onset cerebellar ataxia. Moreover, clinical stabilization by CoQ10 supplementation emphasizes the importance of an early diagnosis.Entities:
Keywords: ADCK3; CoQ10; cerebellar ataxia; mitochondrial disorders; neurodegenerative diseases
Mesh:
Substances:
Year: 2016 PMID: 26818466 PMCID: PMC4950673 DOI: 10.1111/cge.12742
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438